Florida / New York / No Carolina
Ph: 561.316.3330

Fremont Bank Foundation Donates $750,000 to St. Rose Hospital Foundation

To Enhance Its Cardiac Catheterization Laboratory Equipment

Summation

  • , is a STEMI (ST-elevation myocardial infarction) Receiving Center—a designation only given to hospitals where staff can meet rigorous standards of transferring a patient to the cardiac catheterization lab from the emergency room in 90 minutes or less.
  • Rose Hospital is a vital part of our Alameda County ecosystem, and we really listened when its Foundation expressed the importance behind upgrading the catheterization lab machine,” said Brian Hughes, Fremont Bank Executive Vice President and Foundation President and Executive Director.
  • Rose Hospital Foundation for the hospital to purchase a new catalyst cardiac catheterization laboratory machine while keeping services available to Bay Area patients.

Fremont Bank Foundation recently donated $750,000 to its community partner St. Rose Hospital Foundation for the hospital to purchase a new catalyst cardiac catheterization laboratory machine while keeping services available to Bay Area patients.

The innovative Philips Azurion 7 C20 replaces an older cardiac catheterization model recently rendered obsolete.

St. Rose Hospital Foundation regularly receives emergency transports of patients from its facility and other Bay Area hospitals who are suffering from heart attacks and are in need of lifesaving cardiac procedures. St. Rose Hospital, located in Hayward, Calif., is a STEMI (ST-elevation myocardial infarction) Receiving Center—a designation only given to hospitals where staff can meet rigorous standards of transferring a patient to the cardiac catheterization lab from the emergency room in 90 minutes or less.

“Health-care workers need access to the most state-of-the-art equipment in order to provide high-quality services to our patients,” said Michael Cobb, St. Rose Hospital Foundation Executive Director. “Fremont Bank Foundation’s generous contribution allows us to quickly replace an outdated machine while ensuring a seamless continuation of providing top care to the residents of Alameda County and beyond.”

Every year, St. Rose Hospital doctors and nurses perform, on average, more than 400 cardiac diagnostic procedures and manage over 200 STEMI emergencies. In 2021, catheterization laboratory personnel conducted upward of 2,600 non-urgent and emergent cardiac procedures.

“St. Rose Hospital is a vital part of our Alameda County ecosystem, and we really listened when its Foundation expressed the importance behind upgrading the catheterization lab machine,” said Brian Hughes, Fremont Bank Executive Vice President and Foundation President and Executive Director. “This significant gift is one that will keep serving the health of our Bay Area community for years to come.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

- Advertisement -

spot_img

- Advertisement -

Northwell Cardiothoracic Programs Have Nation’s Highest Success Rates

5 Northwell Cardiothoracic Programs (Northwell) include: Long Island Jewish Hospital, Lenox Hill Hospital, South Shore University Hospital, Staten Island University Hospital and the Sandra Atlas Bass Heart Hospital at North Shore University Hospital – received three-star ratings in their respective fields – the highest quality rating possible.

COTA, Baptist Health South Florida, and PreciseDx Announce Collaboration on the AI-Enabled Breast Cancer Recurrence Risk Assessment, PreciseBreast™

“AI has the potential to augment human learning and improve the accuracy and precision of cancer diagnostics and treatments,” said Dr. C.K. Wang, chief medical officer, COTA. “It is critical that we evaluate these tools against the current standard of care to validate their efficacy and build trust in AI and new technologies.”

AscellaHealth CEO, Dea Belazi, Honored as a 2024 PM360 Elite 100 Winner

Dea Belazi said, "This honor truly belongs to the entire AscellaHealth team in recognition of their expertise, dedication and ongoing work that enables patients with complex, chronic conditions to access specialty pharmaceuticals and novel therapies that enhance clinical outcomes."

By using this website you agree to accept Medical Device News Magazine Privacy Policy